Versatile Quidel Quickvue® Respiratory Syncytial Virus (rsv) Flash Sale: 30% Off [TIi6ntS0]

Quidel QuickVue® RSV Test: Fast and Accurate Detection

The Quidel QuickVue® RSV Test is a revolutionary dipstick immunoassay designed for rapid and qualitative detection of respiratory syncytial virus (RSV) antigen. This easy-to-use test kit provides healthcare professionals and laboratories with a quick and reliable tool for diagnosing acute respiratory syncytial viral infections in symptomatic pediatric patients aged eighteen years and younger. With its user-friendly design and efficient results, the QuickVue® RSV Test is a valuable asset for any healthcare setting. Key features include:

• Direct detection of RSV antigen from nasopharyngeal swabs, aspirates, or washes
• 15-minute result time for immediate diagnosis
• High sensitivity and specificity for accurate results

Product Specifications:

Each test kit contains 20 test devices, an extraction reagent bottle, 20 extraction tubes, 20 disposable droppers, 20 nasopharyngeal swabs, a positive RSV control swab, a negative control swab, and a package insert. The test is intended for use as an aid in the diagnosis of acute respiratory syncytial viral infections and is recommended that negative test results be confirmed by cell culture. Important specifications include:

• Tests/Box: 20
• Sample type: Nasopharyngeal swab, aspirate, or wash
• Time to results: 15 minutes
• Accuracy: Sensitivity 92% / Specificity 92%
• Storage: 59°F to 86°F (15°C to 30°C)
• CLIA complexity: Waived
• Certification: FDA

Practical Uses and Benefits:

The Quidel QuickVue® RSV Test is an essential tool for healthcare providers in diagnosing RSV infections in children. Its rapid results enable timely treatment and minimize the risk of complications. The test's accuracy and ease of use make it a valuable addition to any diagnostic toolkit. With its FDA certification and waived CLIA status, the QuickVue® RSV Test is suitable for use in various healthcare settings, including hospitals, clinics, and laboratories. Target audience scenarios include:

• Pediatricians and family physicians for diagnosing RSV infections in children
• Emergency departments for rapid diagnosis of RSV infections
• Public health agencies for monitoring RSV outbreaks